Dong-A Pharmaceutical Co., Ltd.
Dong-A Pharmaceutical Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in South Korea (KR) and has established a significant presence across various operational regions. Founded in 1932, the company has achieved numerous milestones, positioning itself as a leader in the development and manufacturing of innovative healthcare solutions. Specialising in prescription medications, over-the-counter products, and biopharmaceuticals, Dong-A is renowned for its commitment to quality and research-driven approaches. Its core offerings include a diverse range of therapeutic areas, particularly in pain management and infectious diseases, which set it apart in a competitive market. With a strong emphasis on research and development, Dong-A Pharmaceutical has garnered recognition for its contributions to healthcare, solidifying its market position as a trusted provider of effective and safe pharmaceutical products.
DitchCarbon Score
How does Dong-A Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Dong-A Pharmaceutical Co., Ltd.'s score of 20 is lower than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Dong-A Pharmaceutical Co., Ltd.'s reported carbon emissions
Dong-A Pharmaceutical Co., Ltd., headquartered in South Korea (KR), currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been reported. Consequently, there are no details regarding their Scope 1, 2, or 3 emissions. In the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. This lack of information suggests that Dong-A Pharmaceutical may still be in the early stages of formalising its climate strategy and emissions reduction initiatives. As the pharmaceutical industry increasingly prioritises sustainability, Dong-A Pharmaceutical's future commitments and actions will be crucial in aligning with global climate goals and enhancing its environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Dong-A Pharmaceutical Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
